Arndt Hartmann

44.9k citations

715 papers · 21.0k indexed · 2 hit papers · h-index 76

Impact in

Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 130
- Cancer Genomics and Diagnostics 53
Oncology 207
- Cancer Immunotherapy and Biomarkers 62

Co-authors: Abbas Agaimy Robert Stoehr Ferdinand Hofstaedter Edgar Dahl Peter J. Wild Ruth Knuechel Bernd Wullich Matthias W. Beckmann
Journals: Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (37 papers)Cancers (28 papers)The American Journal of Surgical Pathology (23 papers)International Journal of Cancer (22 papers)BMC Cancer (19 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Arndt Hartmann

690 papers receiving 20.7k citations

Hit Papers

align trajectories log scale

Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer 2023 · 141 citations

Peers

Countries citing papers authored by Arndt Hartmann

Since Specialization

Citations

This map shows the geographic impact of Arndt Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arndt Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arndt Hartmann more than expected).

Fields of papers citing papers by Arndt Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arndt Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arndt Hartmann. The network helps show where Arndt Hartmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Arndt Hartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arndt Hartmann Line = papers co-authored together Arndt Hartmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity International Journal of Molecular Sciences ·Judith Sommer, Hanna Ehnis, Tatjana Seitz, Júlia Schneider, Andreas B. Wild, Sandra Moceri, Christa Buechler, Aline Bözec, Georg F. Weber, Susanne Merkel, Ruth Beckervordersandforth, Alexander Steinkasserer, Roland Schüle, Jonel Trebicka, Arndt Hartmann, Anja‐Katrin Bosserhoff, Stephan von Hörsten, Peter Dietrich, Claus Hellerbrand	2023	2
2	On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on Immunotherapy European Urology Oncology ·Jonas Saal, Viktor Grünwald, Tobias Bald, Manuel Ritter, Peter Brossart, Yoshihiko Tomita, Arndt Hartmann, Michael Hölzel, Markus Eckstein, Niklas Klümper	2023	7
3	Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study Cancers ·Frederik A. Stuebs, Anna K. Dietl, Martin C. Koch, Werner Adler, Carol Geppert, Arndt Hartmann, Antje Knöll, Grit Mehlhorn, Matthias W. Beckmann, Carla E. Schulmeyer, Felix Heindl, Julius Emons, Anja Seibold, Annika Behrens, Paul Gaß	2023	2
4	WHOClassification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer Histopathology ·James G. Kench, Mahul B. Amin, Daniel M. Berney, Éva Compérat, Ian A. Cree, Anthony J. Gill, Arndt Hartmann, Santosh Menon, Holger Moch, George J. Netto, Maria Rosaria Raspollini, Mark A. Rubin, Puay Hoon Tan, Toyonori Tsuzuki, Samra Turjalic, Theodorus van der Kwast, Ming Zhou, John R. Srigley	2022	26
5	Select hyperactivating NLRP3 ligands enhance the T _H 1- and T _H 17-inducing potential of human type 2 conventional dendritic cells Science Signaling ·Lukas Hatscher, Christian H.K. Lehmann, Ariawan Purbojo, Constantin Onderka, Chunguang Liang, Arndt Hartmann, Robert Cesnjevar, Heiko Bruns, Olaf Groß, Falk Nimmerjahn, Ivana Ivanović‐Burmazović, Meik Kunz, Lukas Heger, Diana Dudziak	2021	43
6	The HPV and p63 Status in Penile Cancer Are Linked with the Infiltration and Therapeutic Availability of Neutrophils Molecular Cancer Therapeutics ·Muriel Charlotte Bernhard, Anabel Zwick, Tobias Mohr, Gilles Gasparoni, Oybek Khalmurzaev, В. Б. Матвеев, Philine Loertzer, Alexey Pryalukhin, Arndt Hartmann, Carol‐Immanuel Geppert, Hagen Loertzer, Heiko Wunderlich, Carsten Maik Naumann, Holger Kalthoff, Kerstin Junker, Sigrun Smola, Stefan Lohse	2020	8
7	Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor Clinical Cancer Research ·Sibylle Loibl, Karsten E. Weber, Jens Huober, Kristin Krappmann, Frederik Marmé, Christian Schem, Knut Engels, Berit M. Pfitzner, Sherko Kümmel, Jenny Furlanetto, Arndt Hartmann, Silvia Darb‐Esfahani, Volkmar Müller, Annette Staebler, Gϋnter von Minckwitz, Ralf Kronenwett, Carsten Denkert	2018	8
8	Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease Gut ·H Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Räth, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J. Waldner, Jonas Mudter, Arndt Hartmann, Robert Grützmann, Clemens Neufert, Tino Münster, Markus F. Neurath, Raja Atreya	2018	184
9	Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non–Small Cell Lung Carcinoma Cancer Research ·Katerina Kachler, Maximilian Bailer, Lisanne Heim, Fabian Schumacher, Martin Reichel, Corinna D. Holzinger, Sonja Trump, Susanne Mittler, Juliana Monti, Denis I. Trufa, Ralf J. Rieker, Arndt Hartmann, Horia Sı̂rbu, Burkhard Kleuser, Johannes Kornhuber, Susetta Finotto	2017	54
10	Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients Inflammatory Bowel Diseases ·Gheorghe Hundorfean, Mircea T. Chiriac, Sidonia Mihai, Arndt Hartmann, Jonas Mudter, Markus F. Neurath	2017	27
11	Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas The American Journal of Surgical Pathology ·Abbas Agaimy, Matthias Bieg, Michael Michal, Helene Geddert, Bruno Märkl, Jan Seitz, Evgeny A. Moskalev, Matthias Schlesner, Markus Metzler, Arndt Hartmann, Stefan Wiemann, Michal Michal, Thomas Mentzel, Florian Haller	2016	62
12	Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer Clinical Cancer Research ·Sibylle Loibl, Silvia Darb‐Esfahani, Jens Huober, Alexander C. Klimowicz, Jenny Furlanetto, Bianca Lederer, Arndt Hartmann, Holger Eidtmann, Berit M. Pfitzner, Peter A. Fasching, Katharina Tiemann, Christian Jackisch, Keyur Mehta, Gϋnter von Minckwitz, Michael Untch, Carsten Denkert	2016	34
13	pVHL/HIF-Regulated CD70 Expression Is Associated with Infiltration of CD27+ Lymphocytes and Increased Serum Levels of Soluble CD27 in Clear Cell Renal Cell Carcinoma Clinical Cancer Research ·Melanie Ruf, Christiane Mittmann, Anna Nowicka, Arndt Hartmann, Thomas Hermanns, Cédric Poyet, Maries van den Broek, Tullio Sulser, Holger Moch, Peter Schraml	2015	56
14	Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA Cancer Epidemiology Biomarkers & Prevention ·Ross M. Drayton, Ishtiaq Rehman, Raymond A. Clarke, Zhongming Zhao, Karl H. Pang, Saiful Miah, Robert Stoehr, Arndt Hartmann, Sheila Blizard, Martin F. Lavin, Helen E. Bryant, Elena S. Martens‐Uzunova, Guido Jenster, Freddie C. Hamdy, Robert A. Gardiner, James W.F. Catto	2014	9
15	Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11 Clinical Cancer Research ·Ross M. Drayton, Ewa Dudziec, Stefán Péter, Simone Bertz, Arndt Hartmann, Helen E. Bryant, James W.F. Catto	2014	189
16	Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing Molecular Cancer Research ·Martin Hart, Elke Nolte, Sven Wach, Jaroslaw Szczyrba, Helge Täubert, Tilman T. Rau, Arndt Hartmann, Friedrich A. Grässer, Bernd Wullich	2013	74
17	KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy Clinical Cancer Research ·Ashkan Mortezavi, Thomas Hermanns, Hans‐Helge Seifert, Martin Baumgartner, Maurizio Provenzano, Tullio Sulser, Maximilian Burger, M. Montani, Kristian Ikenberg, Ferdinand Hofstädter, Arndt Hartmann, Rolf Jaggi, Holger Moch, Glen Kristiansen, Peter J. Wild	2011	84
18	Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma Molecular Cancer Research ·Jaroslaw Szczyrba, Elke Nolte, Sven Wach, Elisabeth Kremmer, Robert Stöhr, Arndt Hartmann, Wolf F. Wieland, Bernd Wullich, Friedrich A. Grässer	2011	96
19	The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing Molecular Cancer Research ·Jaroslaw Szczyrba, Elke Löprich, Sven Wach, Volker Jung, Gerhard Unteregger, Stephanie Barth, Rainer Grobholz, Wolf F. Wieland, Robert Stöhr, Arndt Hartmann, Bernd Wullich, Friedrich A. Grässer	2010	193
20	Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy Clinical Cancer Research ·Raihanatou Diallo-Danebrock, Evelyn Ting, Oleg Gluz, Alexander Herr, Svjetlana Mohrmann, Helene Geddert, Achim Rody, Karl‐Ludwig Schaefer, Stephan Baldus, Arndt Hartmann, Peter J. Wild, Michael Burson, Helmut E. Gabbert, Ulrike Nitz, Christopher Poremba	2007	57

About Arndt Hartmann

Arndt Hartmann is a scholar working on Cancer Research, Oncology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 715 papers that have together received 21.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (169 papers), Urinary and Genital Oncology Studies (131 papers), Cancer Immunotherapy and Biomarkers (62 papers), Epigenetics and DNA Methylation (60 papers), Renal cell carcinoma treatment (57 papers), Cancer Genomics and Diagnostics (53 papers), Genetic factors in colorectal cancer (48 papers) and Renal and related cancers (45 papers). The work is most often cited by research in Cancer Research (4.5k citations), Oncology (6.0k citations), Gastroenterology (832 citations), Pulmonary and Respiratory Medicine (4.9k citations) and Surgery (6.4k citations). Arndt Hartmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Abbas Agaimy, Robert Stoehr, Ferdinand Hofstaedter, Edgar Dahl, Peter J. Wild, Ruth Knuechel, Bernd Wullich, Matthias W. Beckmann, Stefan Denzinger and Wolfgang Dietmaier. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Cancers, The American Journal of Surgical Pathology, International Journal of Cancer and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact